James Bylund, Chief Operating Officer at REPLIGEN CORP (RGEN), sold 8,746 shares at $198.08 ($1.7M) on 2024-02-23, disclosed to the SEC on 2024-02-26.
Open-market sale of $1.7M RGEN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.08 | 4,373 | $866K | 50.0% |
| 2 | $198.08 | 4,373 | $866K | 50.0% |
| Total | $198.08 avg | 8,746 | $1.7M | 100% |
| Filing → |
| RGEN | SELL | 2021-04-08 | $74K | — | Filing → |